1. Home
  2. PDYN vs CABA Comparison

PDYN vs CABA Comparison

Compare PDYN & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Palladyne AI Corp.

PDYN

Palladyne AI Corp.

HOLD

Current Price

$7.11

Market Cap

292.0M

Sector

Industrials

ML Signal

HOLD

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$2.87

Market Cap

319.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDYN
CABA
Founded
1983
2017
Country
United States
United States
Employees
70
N/A
Industry
Wholesale Distributors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
292.0M
319.6M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
PDYN
CABA
Price
$7.11
$2.87
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$9.67
$14.50
AVG Volume (30 Days)
2.0M
3.4M
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.26
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$384.48
N/A
Revenue Next Year
$63.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.14
$1.26
52 Week High
$12.79
$4.23

Technical Indicators

Market Signals
Indicator
PDYN
CABA
Relative Strength Index (RSI) 51.70 34.39
Support Level $5.89 $2.58
Resistance Level $7.77 $3.48
Average True Range (ATR) 0.79 0.27
MACD -0.14 -0.08
Stochastic Oscillator 36.46 7.76

Price Performance

Historical Comparison
PDYN
CABA

About PDYN Palladyne AI Corp.

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: